References
- Lionello M, Stritoni P, Facciolo MC, et al. Temporal bone carcinoma. Current diagnostic, therapeutic, and prognostic concepts. J Surg Oncol. 2014;110(4):383–392.
- Zanoletti E, Lovato A, Stritoni P, et al. A critical look at persistent problems in the diagnosis, staging and treatment of temporal bone carcinoma. Cancer Treat Rev. 2015;41(10):821–826.
- Essandoh K, Fan GC. Role of extracellular and intracellular microRNAs in sepsis. Biochim Biophys Acta. 2014;1842(11):2155–2162.
- Rokavec M, Li H, Jiang L, et al. The p53/miR-34 axis in development and disease. J Mol Cell Biol. 2014;6(3):214–230.
- Lefort K, Brooks Y, Ostano P, et al. A miR-34a-SIRT6 axis in the squamous cell differentiation network. EMBO J. 2013;32(16):2248–2263.
- Carron J, Torricelli C, Silva JK, et al. microRNAs deregulation in head and neck squamous cell carcinoma. Head Neck. 2021;43(2):645–667.
- Wang L, Yu J, Xu J, et al. The analysis of microRNA-34 family expression in human cancer studies comparing cancer tissues with corresponding pericarcinous tissues. Gene 2015;554(1):1–8.
- Nelson PT, Baldwin DA, Kloosterman WP, et al. RAKE and LNA-ISH reveal microRNA expression and localization in RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain. RNA 2006;12(2):187–191.
- Dave VP, Ngo TA, Pernestig AK, et al. MicroRNA amplification and detection technologies: opportunities and challenges for point of care diagnostics. Lab Invest. 2019;99(4):452–469.
- Akiyama N, Yamamoto-Fukuda T, Yoshikawa M, et al. Regulation of DNA methylation levels in the process of oral mucosal regeneration in a rat oral ulcer model. Histol Histopathol. 2020;35(3):247–256.
- Son KD, Kim TJ, Lee YS, et al. Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin. J Surg Oncol. 2008;97(7):615–620.
- Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671–675.
- Zeineh MM, Chen Y, Kitzler HH, et al. Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease. Neurobiol Aging. 2015;36(9):2483–2500.
- Alessandrini L, Astolfi L, Franz L, et al. Temporal bone squamous cell carcinoma: molecular markers involved in carcinogenesis, behavior, and prognosis: a systematic review. Int J Mol Sci. 2022;23(9):4536.
- Bosari S, Viale G. The clinical significance of p53 aberrations in human tumours. Virchows Arch. 1995;427(3):229–241.
- Bailey MH, Tokheim C, Porta-Pardo E, Cancer Genome Atlas Research Network, et al. Comprehensive characterization of cancer driver genes and mutations. Cell 2018;173(2):371–385.
- Xue Y, San Luis B, Lane DP. Intratumour heterogeneity of p53 expression; causes and consequences. J Pathol. 2019;249(3):274–285.
- Li S, Wei X, He J, et al. The comprehensive landscape of miR-34a in cancer research. Cancer Metastasis Rev. 2021;40(3):925–948.
- Chang T-C, Wentzel EA, Kent OA, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell. 2007;26(5):745–752.
- Lodygin D, Tarasov V, Epanchintsev A, et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle. 2008;7(16):2591–2600.